Study guide
1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination
BCEMP Board Certified Emergency Medicine Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction, Triage, and Resuscitation Fundamentals
1.1 BCEMP Exam Logistics, Content Outlines & Scoring 1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination 1.3 Resuscitation Pharmacology, Pharmacokinetics & Vascular Access
2 Chapter 2: Cardiac Arrest and Dysrhythmias
2.1 Adult Cardiac Arrest & ACLS Pharmacotherapy Protocols 2.2 Acute Tachyarrhythmias: Narrow- and Wide-Complex Management 2.3 Symptomatic Bradycardia & Vasoactive Chronotropic Support 2.4 Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)
3 Chapter 3: Shock and Hemodynamic Resuscitation
3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation 3.2 Cardiogenic & Obstructive Shock, Mechanical Circulatory Support & LVADs 3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
4 Chapter 4: Airway Management and Rapid Sequence Intubation (RSI)
4.1 Rapid Sequence Intubation (RSI) Process & Pretreatment Agents 4.2 RSI Induction Agents: Pharmacology, Selection & Dosing 4.3 Neuromuscular Blocking Agents & Post-Intubation Analgosedation
5 Chapter 5: Neurocritical Care and Neurologic Emergencies
5.1 Acute Ischemic Stroke: Thrombolysis & Blood Pressure Control 5.2 Intracranial Hemorrhage & Elevated ICP Pharmacotherapy 5.3 Status Epilepticus: Tiered Emergent Anticonvulsant Therapy 5.4 Traumatic Brain Injury & Spinal Cord Emergencies
6 Chapter 6: Acute Coronary Syndromes and Acute Heart Failure
6.1 Acute Coronary Syndromes: STEMI & NSTE-ACS Pharmacotherapy 6.2 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 6.3 Hypertensive Crises: Emergencies, Urgencies & Target Blood Pressure
7 Chapter 7: Pulmonary and Allergic Emergencies
7.1 Acute Pulmonary Embolism: Risk Stratification & Thrombolytic Therapy 7.2 Severe Asthma Exacerbation & COPD Acute Management 7.3 Anaphylaxis & Severe Allergic Reactions: Acute Epinephrine Protocols
8 Chapter 8: Clinical Toxicology: Approach to Poisoning and Common Overdoses
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination 8.2 Acetaminophen Overdose & N-Acetylcysteine Dosing Strategies 8.3 Salicylate Toxicity & Toxic Alcohol Management (Fomepizole) 8.4 Opioid Toxicity & Sedative-Hypnotic/Alcohol Withdrawal Syndromes 8.5 Beta-Blocker & Calcium Channel Blocker Toxicity (HIET, Calcium, Glucagon)
9 Chapter 9: Toxicology: Specialized Poisonings and Antidotes
9.1 Digoxin, Tricyclic Antidepressants & Anticholinergic Toxicity 9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins 9.3 Snake and Spider Envenomations & Heavy Metal Chelation 9.4 Additional Antidotes: Methemoglobinemia, Isoniazid, Sulfonylureas, Valproate, Sympathomimetics & LAST
10 Chapter 10: Hemostasis, Anticoagulant Reversal, and Hematology
10.1 DOAC & Warfarin Reversal: Specific Reversal Agents & 4F-PCC 10.2 Heparin-Induced Thrombocytopenia (HIT) & Direct Thrombin Inhibitors 10.3 Sickle Cell Vaso-Occlusive Crises & Acute Chest Syndrome
11 Chapter 11: Endocrine, Electrolyte, and Metabolic Emergencies
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Severe Electrolyte Emergencies: Hyperkalemia & Hyponatremia 11.3 Endocrine Crises: Thyroid Storm, Myxedema Coma & Acute Adrenal Crisis 11.4 Acute Kidney Injury, Dialyzability & Drug Dosing during RRT
12 Chapter 12: Infectious Diseases and Antimicrobial Stewardship
12.1 Severe Community & Hospital-Acquired Infections in the ED 12.2 Skin & Soft Tissue, STI, and Vector-Borne Emergencies 12.3 ED Antimicrobial Stewardship & Rapid Microbiologic Diagnostics
13 Chapter 13: Special Populations: Pediatrics, Trauma, and Obstetrics
13.1 Pediatric Resuscitation, Status Epilepticus & PALS Pharmacotherapy 13.2 Trauma Pharmacotherapy: Massive Transfusion, TXA, Open Fractures, Tetanus & Burns 13.3 Obstetric & Gynecologic Emergencies: Preeclampsia, Eclampsia & PPH
14 Chapter 14: Medication Safety, ED Operations, and Disaster Preparedness
14.1 ED High-Alert Medications, Error Reporting & Technology Safeguards 14.2 ED Workflow, Transitions of Care & Boarding Patient Management 14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles
15 Chapter 15: Biostatistics, Study Design, and Literature Evaluation
15.1 Biostatistics & Hypothesis Testing: Power, Errors & Interpretations 15.2 Clinical Study Designs & Measures of Effect 15.3 Literature Evaluation, Clinical Guidelines & Research Conduct in the ED
16 Chapter 16: Medical Devices, Ventilation, and Medication Delivery
16.1 Mechanical Ventilation, Noninvasive Ventilation & High-Flow Oxygen: What the Pharmacist Must Know 16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management 16.3 Infusion Pumps, Patient-Owned Devices & Medication Delivery Device Counseling
17 Chapter 17: Organ-System Emergencies: GI, GU, Oncology, Neurology, ENT, Pain, and Psychiatry
17.1 Gastrointestinal & Hepatic Emergencies: GI Bleeding, Cirrhosis Complications, Pancreatitis & Vomiting 17.2 Genitourinary Emergencies: UTI & Pyelonephritis, Renal Colic, Urinary Retention, Priapism & Scrotal Infections 17.3 Oncologic, Immunotherapy & Hematologic Emergencies: Febrile Neutropenia, TLS, Hypercalcemia, irAEs, CAR-T, Hemophilia & TTP 17.4 Headache & Neuromuscular Emergencies: Migraine, Cluster, Myasthenic Crisis, Guillain-Barré & Bell's Palsy 17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain 17.6 Acute Pain Management & Procedural Sedation and Analgesia in the ED 17.7 Psychiatric Emergencies: Severe Agitation, Serotonin Syndrome, NMS, Lithium Toxicity & Psychotropic Overdose
18 Chapter 18: Special Populations, Medication Access, and Professional Practice
18.1 Pharmacogenomics, Adverse Drug Events & High-Risk Drug Interactions in Emergency Care 18.2 Special Populations: Older Adults, Extremes of Weight, Pregnancy & Lactation, and Immunocompromised Patients 18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge 18.4 Healthcare Regulations & Standards: FDA, REMS, Bar Coding, DEA, CMS, EMTALA, The Joint Commission, NIOSH & USP 18.5 Formulary & Inventory Management, Drug Shortages, Antidote Stocking & Clinical Decision Support 18.6 Quality Improvement, Practice Standards & Interprofessional Collaboration (Protocols, Teamwork & Debriefing)
1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination
Key Takeaways Explain This Topic AI
The Emergency Severity Index (ESI) is a validated 5-level triage algorithm that stratifies patients based on clinical acuity (Levels 1 and 2) and anticipated resource consumption (Levels 3, 4, and 5).
ESI Level 1 requires immediate life-saving hemodynamic or airway intervention; ESI Level 2 identifies high-risk presentations, acute altered mental status, or severe pain/distress without hemodynamic collapse.
Resource counting distinguishes distinct diagnostic and therapeutic modalities: blood/urine labs count as one resource, while oral medications, saline locks, and routine wound checks consume zero resources.
Geriatric and neonatal triage requires heightened vigilance: neonates under 28 days with fever (>=38.0°C) automatically meet ESI 2 criteria, while elderly patients frequently display blunted tachycardia and atypical shock presentations.
Last updated: October 2026
1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination
Note
Triage establishes the initial clinical trajectory for emergency department care. Pharmacists positioned near triage intercept medication-induced presentations and guide rapid resuscitation orders.
The Emergency Severity Index (ESI) Algorithm
Triage in the emergency department is a rapid assessment process designed to sort patients based on clinical urgency rather than arrival sequence. The most widely implemented triage architecture in North America is the Emergency Severity Index (ESI) , a five-level algorithm that stratifies patients through four sequential decision points based on acuity, high-risk clinical features, and anticipated hospital resource utilization. ESI TRIAGE DECISION ALGORITHM
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ Decision Point A: Does the patient require immediate life-saving │
- │ intervention? (Airway, breathing, circulation, AVPU=P/U) │
- └──────────────────────┬──────────────────────────────────────────────────────┘
- │
- YES ────────────┴──────────── NO
- │ │
- ▼───────▼ ▼
- │ ESI 1 │ ┌──────────────────────────────────────────────┐
- └───────┘ │ Decision Point B: Is this a high-risk │
- │ situation? Confused, lethargic, disoriented? │
- │ Severe pain or distress? │
- └────────────────────┬─────────────────────────┘
- │
- YES ────────────┴──────────── NO
- │ │
- ▼───────▼ ▼
- │ ESI 2 │ ┌───────────────────────────────┐
- └───────┘ │ Decision Point C: How many │
- │ resources will be needed? │
- └──────────────┬────────────────┘
- │
- ┌────────────────────────┬───────────────┴────────────────┐
- ▼ ▼ ▼
- NONE ONE TWO OR MORE
- │ │ │
- ▼───────▼ ▼───────▼ ▼
- │ ESI 5 │ │ ESI 4 │ ┌─────────────────────────┐
- └───────┘ └───────┘ │ Decision Point D: Check │
- │ danger zone vitals │
- └────────────┬────────────┘
- │
- DANGER ZONE ─────┴───── NORMAL
- │ │
- ▼───────▼ ▼───────▼
- │ ESI 2 │ │ ESI 3 │
- └───────┘ └───────┘
- ESI Decision Points Detailed
- Decision Point A: Immediate Life-Saving Interventions (ESI Level 1)
Does the patient present with an immediate life-threatening physiological derangement requiring immediate physician and nursing intervention to prevent death?
Clinical Indicators : Apnea, agonal respirations, severe respiratory distress with bradypnea or exhaustion, pulseless cardiac arrest, profound unresponsiveness (AVPU scale = 'P' [responds only to Pain] or 'U' [Unresponsive] with acute airway/breathing compromise), profound hypotension with absent peripheral pulses, or anaphylactic shock with stridor.
Life-Saving Interventions : Endotracheal intubation, surgical cricothyrotomy, bag-valve-mask ventilatory support, emergent defibrillation or synchronized cardioversion, immediate push-dose vasopressors or continuous vasopressor infusions, massive crystalloid/blood resuscitation, needle decompression, or emergent tube thoracostomy.
Non-Life-Saving Interventions : Diagnostic blood draws, peripheral IV cannula placement without resuscitation, non-rebreather oxygen in a stable patient, or oral medications do not qualify a patient as ESI 1.
Decision Point B: High-Risk Situations & Altered States (ESI Level 2)
If the patient does not meet ESI 1, the triage clinician assesses three key questions:
Is this a high-risk situation? A condition that could rapidly deteriorate into a life- or limb-threatening state if care is delayed (e.g., active chest pain consistent with acute coronary syndrome, acute focal neurologic deficits within the thrombolytic/endovascular window, signs of ruptured ectopic pregnancy, testicular or ovarian torsion, acute compartment syndrome, immunocompromised/neutropenic patient with fever, or severe suicidal/homicidal ideation with lethal intent).
Is the patient confused, lethargic, or disoriented? An acute change in mental status, new encephalopathy, delirium, or severe toxic ingestion.
Is the patient in severe pain or distress? Severe physical pain rated ≥7/10 on a numeric rating scale requiring immediate parenteral opioid analgesia, acute sexual assault victims, or severe behavioral agitation posing immediate threat to staff or self.
Decision Point C: Predicted Resource Utilization (ESI Levels 3, 4, 5)
If the patient is not ESI 1 or 2, acuity is determined by predicting the number of different hospital resource categories required to reach a disposition:
Zero Resources → \rightarrow → ESI Level 5 (e.g., suture removal, prescription refill, simple non-infected rash with normal vitals, chronic joint pain without acute injury).
One Resource → \rightarrow → ESI Level 4 (e.g., simple laceration repair requiring sutures, single plain radiograph of an isolated extremity injury, uncomplicated dysuria requiring a clean-catch urine dip and oral antibiotic prescription).
Two or More Resources → \rightarrow → Proceed to Decision Point D (preliminary ESI Level 3).
Decision Point D: Danger Zone Vital Signs (ESI 3 vs. ESI 2 Up-Triage)
When two or more resources are anticipated, vital signs are evaluated against age-stratified danger thresholds. If a vital sign exceeds the danger zone, the triage clinician must evaluate whether to up-triage the patient from ESI 3 to ESI Level 2 :
- Age Group Heart Rate (beats/min) Respiratory Rate (breaths/min) Oxygen Saturation ( S p O 2 SpO_2 Sp O 2 )
- < 3 <3 < 3 months > 180 >180 > 180 > 50 >50 > 50 < 92 % <92\% < 92%
- 3 months to 3 years > 160 >160 > 160 > 40 >40 > 40 < 92 % <92\% < 92%
- 3 to 8 years > 140 >140 > 140 > 30 >30 > 30 < 92 % <92\% < 92%
- > 8 >8 > 8 years to Adult > 100 >100 > 100 > 20 >20 > 20 < 92 % <92\% < 92%
- Resource Accounting: What Counts vs. What Does Not
ESI defines resources based on hospital consumption, diagnostic testing, and therapeutic intensity. Misidentifying resources is a primary cause of triage misclassification.
Clinical Modality Counts as an ESI Resource Does NOT Count as an ESI Resource
Laboratory Testing Blood tests (CBC, BMP, troponin, coagulation, blood cultures), CSF analysis, urine microscopy sent to central lab (all combined = 1 resource) Point-of-care fingerstick blood glucose, rapid urine pregnancy test, clean-catch dipstick without lab send-out
Diagnostic Imaging Plain radiographs, CT scans, MRI, diagnostic ultrasound, nuclear medicine studies (each imaging modality = 1 resource) Point-of-care bedside ultrasound (POCUS) used purely as physical exam adjunct, bladder scan
Medications Intravenous, intramuscular, subcutaneous, or nebulized medications; procedural sedation agents Oral medications, prescription refills, routine tetanus toxoid booster, topical ointments
Vascular Access & Fluids Intravenous fluid hydration (crystalloid bolus or maintenance infusion) Peripheral IV saline lock placement without fluid administration
Procedures & Consults Specialty physician consultation, chest tube thoracostomy, lumbar puncture, complex wound repair Simple suture removal, crutch fitting, simple sling or splint application, wound cleansing/dressing
Warning
Under ESI rules, all laboratory tests count as only ONE resource , regardless of how many tubes of blood or body fluids are collected. Similarly, multiple plain radiographs (e.g., chest, pelvis, and femur) count as one single imaging resource .
- Pediatric & Geriatric Triage Nuances
- Pediatric Triage Considerations
Physiologic Compensation : Children compensate for shock via profound vasoconstriction and tachycardia, maintaining normal blood pressure until cardiovascular collapse is catastrophic. Triage must assess the Pediatric Assessment Triangle (PAT): Appearance (tone, interactiveness, gaze), Work of Breathing (retractions, nasal flaring, grunting), and Circulation to Skin (pallor, mottling, cyanosis, capillary refill > 2 >2 > 2 seconds).
Neonatal Fever Threshold : Any infant under 28 days of age with a documented rectal temperature ≥38.0°C (100.4°F) automatically meets criteria for ESI Level 2 (High Risk) , regardless of appearing well. Neonates lack mature blood-brain barriers and immune responses, carrying an elevated risk of invasive bacterial illness (Group B Streptococcus, Listeria monocytogenes, E. coli) requiring lumbar puncture, blood cultures, and empiric parenteral antibiotics (the 2021 AAP febrile infant guideline uses ampicillin plus gentamicin or ceftazidime, with ceftazidime when meningitis is suspected).
Geriatric Triage Considerations
Blunted Hemodynamics : Resting tachycardia may be entirely masked by beta-blockers, non-dihydropyridine calcium channel blockers, or intrinsic sinoatrial node disease. A "normal" heart rate of 75 beats/min in an elderly patient in septic shock may represent severe relative bradycardia.
Atypical Infection Presentations : Older adults frequently fail to mount a febrile response during severe sepsis or pneumonia; hypothermia, acute delirium, or failure to thrive may be the sole presenting sign.
Occult Intracranial Hemorrhage : Any ground-level fall in an elderly patient receiving therapeutic anticoagulation (warfarin, direct oral anticoagulants) warrants immediate ESI 2 consideration for emergent non-contrast head CT.
Pre-Hospital Coordination & EMS Handoff
Effective emergency department throughput relies on seamless pre-hospital coordination. Emergency medical services (EMS) providers communicate clinical data during handoff using standardized frameworks:
The MIST Handoff Framework
M — Mechanism / Medical Complaint : High-velocity motor vehicle crash, fall from height, or onset timing of medical symptoms.
I — Injuries Identified / Illness : Anatomic injuries, acute focal deficits, or rhythm abnormalities.
S — Signs & Vital Signs : Trended blood pressure, heart rate, respiratory rate, S p O 2 SpO_2 Sp O 2 , and Glasgow Coma Scale (GCS).
T — Treatments Administered & Response : Fluid volumes infused, medications given (e.g., fentanyl, naloxone, epinephrine), splinting, and airway interventions.
EMS Medication Systems and the Pharmacist
Pre-hospital care is a pharmacy problem as much as a transport problem. The emergency medicine pharmacist commonly helps the EMS medical director with:
Drug box and formulary design : standardized concentrations (for example, one epinephrine strength for push-dose use), weight-based pediatric dosing cards, and substitutions during shortages.
Controlled substances : the Protecting Patient Access to Emergency Medications Act of 2017 amended the Controlled Substances Act so that an EMS agency can hold a DEA registration and its professionals can administer controlled substances (fentanyl, ketamine, midazolam) under standing orders or verbal orders from the agency medical director. Accountability rules (storage, restocking, waste and records) still apply.
Hospital restocking and handoff : reconciling what was given in the field (drug, dose, time) so doses are not duplicated in the ED. A second dose of IM epinephrine, naloxone or midazolam given on arrival is a classic error when field doses go unrecorded.
Protocol updates : updating field protocols to match current guidelines (for example, prehospital TXA for injured patients within 3 hours, or IM midazolam for status epilepticus from the RAMPART trial).
Medical Control Frameworks
Offline Medical Direction (Standing Orders) : Protocols approved by the medical director enabling pre-hospital clinicians to execute time-critical interventions without physician contact (e.g., IM epinephrine for anaphylaxis, naloxone for opioid overdose, dextrose for hypoglycemia, albuterol for bronchospasm, chewable aspirin for suspected ACS, CPR/defibrillation protocols).
Online Medical Direction : Direct, real-time communication via radio or telephone with an emergency physician for high-risk or ambiguous situations: field termination of resuscitation, pediatric procedural sedation, refusal of transport against medical advice (AMA) in impaired individuals, or administration of specialized antidotes.
Pharmacist-Led Medication Reconciliation at Initial Triage
Positioning emergency pharmacists at triage or in rapid-assessment intake areas intercepts high-risk medication errors and identifies drug-induced etiologies before orders are placed:
Anticoagulants & Antiplatelets : Immediate identification of warfarin, apixaban, rivaroxaban, or dabigatran in patients presenting with intracranial hemorrhage, massive gastrointestinal bleeding, or major trauma triggers rapid order activation for 4F-PCC or idarucizumab (andexanet alfa left the US market in December 2025).
Cardiovascular Agents : Detecting recent ingestions of beta-blockers, calcium channel blockers, or digoxin clarifies etiology in undifferentiated bradycardia and shock.
Immune & Endocrine Modifiers : Identifying chronic corticosteroid therapy identifies patients at risk for acute adrenal crisis during septic shock; recognizing SGLT2 inhibitor therapy identifies euglycemic diabetic ketoacidosis (DKA).
Drug-Induced Angioedema : Identifying ACE inhibitor therapy in patients presenting with tongue or lip swelling prevents inappropriate histamine-targeted therapy (antihistamines, corticosteroids) and directs rapid airway stabilization and specialized kallikrein-kinin pathway evaluation.